203 related articles for article (PubMed ID: 21998343)
1. The impact of delayed storage on the measured proteome and metabolome of human cerebrospinal fluid.
Rosenling T; Stoop MP; Smolinska A; Muilwijk B; Coulier L; Shi S; Dane A; Christin C; Suits F; Horvatovich PL; Wijmenga SS; Buydens LM; Vreeken R; Hankemeier T; van Gool AJ; Luider TM; Bischoff R
Clin Chem; 2011 Dec; 57(12):1703-11. PubMed ID: 21998343
[TBL] [Abstract][Full Text] [Related]
2. The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).
Rosenling T; Slim CL; Christin C; Coulier L; Shi S; Stoop MP; Bosman J; Suits F; Horvatovich PL; Stockhofe-Zurwieden N; Vreeken R; Hankemeier T; van Gool AJ; Luider TM; Bischoff R
J Proteome Res; 2009 Dec; 8(12):5511-22. PubMed ID: 19845411
[TBL] [Abstract][Full Text] [Related]
3. Qualitative metabolome analysis of human cerebrospinal fluid by 13C-/12C-isotope dansylation labeling combined with liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry.
Guo K; Bamforth F; Li L
J Am Soc Mass Spectrom; 2011 Feb; 22(2):339-47. PubMed ID: 21472593
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples.
Stoop MP; Coulier L; Rosenling T; Shi S; Smolinska AM; Buydens L; Ampt K; Stingl C; Dane A; Muilwijk B; Luitwieler RL; Sillevis Smitt PA; Hintzen RQ; Bischoff R; Wijmenga SS; Hankemeier T; van Gool AJ; Luider TM
Mol Cell Proteomics; 2010 Sep; 9(9):2063-75. PubMed ID: 20811074
[TBL] [Abstract][Full Text] [Related]
5. Pre-analytical factors influencing the stability of cerebrospinal fluid proteins.
Simonsen AH; Bahl JM; Danborg PB; Lindstrom V; Larsen SO; Grubb A; Heegaard NH; Waldemar G
J Neurosci Methods; 2013 May; 215(2):234-40. PubMed ID: 23537933
[TBL] [Abstract][Full Text] [Related]
6. Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS.
Wuolikainen A; Hedenström M; Moritz T; Marklund SL; Antti H; Andersen PM
Amyotroph Lateral Scler; 2009 Aug; 10(4):229-36. PubMed ID: 19412814
[TBL] [Abstract][Full Text] [Related]
7. Robust two-dimensional separation of intact proteins for bottom-up tandem mass spectrometry of the human CSF proteome.
Bora A; Anderson C; Bachani M; Nath A; Cotter RJ
J Proteome Res; 2012 Jun; 11(6):3143-9. PubMed ID: 22537003
[TBL] [Abstract][Full Text] [Related]
8. Differences in metabolite profiles caused by pre-analytical blood processing procedures.
Nishiumi S; Suzuki M; Kobayashi T; Yoshida M
J Biosci Bioeng; 2018 May; 125(5):613-618. PubMed ID: 29258730
[TBL] [Abstract][Full Text] [Related]
9. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
10. A global HILIC-MS approach to measure polar human cerebrospinal fluid metabolome: Exploring gender-associated variation in a cohort of elderly cognitively healthy subjects.
Gallart-Ayala H; Konz I; Mehl F; Teav T; Oikonomidi A; Peyratout G; van der Velpen V; Popp J; Ivanisevic J
Anal Chim Acta; 2018 Dec; 1037():327-337. PubMed ID: 30292309
[TBL] [Abstract][Full Text] [Related]
11. Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update.
Mandal R; Guo AC; Chaudhary KK; Liu P; Yallou FS; Dong E; Aziat F; Wishart DS
Genome Med; 2012 Apr; 4(4):38. PubMed ID: 22546835
[TBL] [Abstract][Full Text] [Related]
12. The human cerebrospinal fluid metabolome.
Wishart DS; Lewis MJ; Morrissey JA; Flegel MD; Jeroncic K; Xiong Y; Cheng D; Eisner R; Gautam B; Tzur D; Sawhney S; Bamforth F; Greiner R; Li L
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):164-73. PubMed ID: 18502700
[TBL] [Abstract][Full Text] [Related]
13. Polar anionic metabolome analysis by nano-LC/MS with a metal chelating agent.
Myint KT; Uehara T; Aoshima K; Oda Y
Anal Chem; 2009 Sep; 81(18):7766-72. PubMed ID: 19702289
[TBL] [Abstract][Full Text] [Related]
14. Effects of differences in pre-analytical processing on blood protein profiles determined with SWATH-MS.
Nambu M; Nishiumi S; Kobayashi T; Masuda T; Ito S; Yoshida M; Ohtsuki S
J Proteomics; 2020 Jul; 223():103824. PubMed ID: 32445911
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
[TBL] [Abstract][Full Text] [Related]
16. Metabolite quantification by NMR and LC-MS/MS reveals differences between unstimulated, stimulated, and pure parotid saliva.
Figueira J; Gouveia-Figueira S; Öhman C; Lif Holgerson P; Nording ML; Öhman A
J Pharm Biomed Anal; 2017 Jun; 140():295-300. PubMed ID: 28380387
[TBL] [Abstract][Full Text] [Related]
17. Validation of a method for the determination of AMG 579 in cerebrospinal fluid with a focus on sample collection procedures for clinical trials.
Wilson SF; Kerr SJ; Rose MJ; James CA
J Pharm Biomed Anal; 2015 Apr; 108():49-55. PubMed ID: 25706859
[TBL] [Abstract][Full Text] [Related]
18. Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics.
Marshall DD; Powers R
Prog Nucl Magn Reson Spectrosc; 2017 May; 100():1-16. PubMed ID: 28552170
[TBL] [Abstract][Full Text] [Related]
19. Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples.
Breier M; Wahl S; Prehn C; Fugmann M; Ferrari U; Weise M; Banning F; Seissler J; Grallert H; Adamski J; Lechner A
PLoS One; 2014; 9(2):e89728. PubMed ID: 24586991
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
